About Us

Back to About Us

Kathleen Schmainda, Ph.D., M.A., MSEEE, BSE

Associate Scholar

Dr. Schmainda’s research involves the advancement of MRI technologies to improve the diagnosis, monitoring, and development of new treatments for brain and other cancers. This research includes experience with software development, clinical trials, use of preclinical models, tissue banking, and frequent interaction with the IRB (Institutional Review Board). Dr. Schmainda is an internationally invited speaker on these research topics and has served on numerous National Institutes of Health (NIH) grant review panels as well as several national advisory boards for clinical trials. She serves as a faculty mentor for medical student pro-life groups and is a board member of the national organization, University Faculty for Life. Dr. Schmainda also co-founded two high tech start-up companies both of which have produced FDA-cleared medical imaging software products used worldwide.

Latest Research & News

  • The Coronavirus Pandemic and the Ethics of Triage | March 26, 2020

    by R. J. Snell, Ph.D. This paper can be viewed as a pdf here: The Coronavirus Pandemic and the Ethics of Triage   As the COVID-19 pandemic continues in Italy, many hospitals are overwhelmed with patients, necessitating difficult triage decisions that can seem like choosing who lives and who dies. In the United States, already […]

  • Pro-Life Topics for Lawmakers Regarding Coronavirus | March 25, 2020

    This is Issue 43 in CLI’s On Point Series. To view this report as a PDF, see: On Point 43 Pro-Life Topics for Lawmakers Regarding Coronavirus.   Abortion advocates have found a new ally—COVID-19.   During this intensely stressful time, the vast majority of Americans are focused on protecting their health and the health of […]